Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aspira Women's Health
AddedFeb 20, 2024
UpdatedJun 18, 2026
Aspira Women's Health

Aspira Women's Health

Public

Biotech firm, Aspira Women's Health Inc., pioneers diagnostic tests and treatments for gynecologic issues in Texas.

HQ
Austin, TX, US
Founded
2000
Overview
Compare
Fundraising
Employees
News
Website

Aspira Women's Health Inc., a biotech firm, was founded with the mission to transform women's gynecologic health, starting with ovarian cancer. The company focuses on the discovery, development, and commercialization of innovative diagnostic tests and treatments for gynecologic issues. Aspira Women's Health aims to provide early detection solutions for ovarian cancer risk, striving to improve outcomes for women of all races and ethnicities, regardless of menopausal status. Their market focus is primarily in Texas.

Notable affiliated individuals include key researchers and medical professionals specializing in gynecology and oncology. Aspira Women's Health has garnered attention from significant investors in the biotech and healthcare sectors. Key achievements include the development of advanced diagnostic tests that have the potential to revolutionize early detection and treatment of ovarian cancer. The company's impact lies in its commitment to improving women's health outcomes through cutting-edge biotechnology.

Aspira Women's Health - Similar Companies

Ovagene Oncology logo

Ovagene Oncology

Hera Biotech logo

Hera Biotech

herabiotech.com

Oviva Therapeutics logo

Oviva Therapeutics

ovivatx.com

Avant Diagnostics logo

Avant Diagnostics

OncoHealth logo

OncoHealth

oncohealthcorp.com

AOA Dx logo

AOA Dx

aoadx.com

Nanopath logo

Nanopath

nanopathdx.com

viO HealthTech logo

viO HealthTech

viohealthtech.com

Caza Health logo

Caza Health

cazahealth.com

Advantia Health logo

Advantia Health

advantiahealth.com

Castle Biosciences logo

Castle Biosciences

Myriad Genetics logo

Myriad Genetics

myriad.com

Daré Bioscience logo

Daré Bioscience

darebioscience.com

Femasys logo

Femasys

femasys.com

GynMobileHealth logo

GynMobileHealth

Aspira Women's Health - Quick Facts

Who are Aspira Women's Health's competitors?

Companies similar to Aspira Women's Health include Ovagene Oncology, Hera Biotech, Oviva Therapeutics and Avant Diagnostics.

When was Aspira Women's Health founded?

Aspira Women's Health was founded in 2000.

Where is Aspira Women's Health's headquarters located?

Aspira Women's Health's headquarters is located in Austin, TX, US.

When was Aspira Women's Health's last funding round?

Aspira Women's Health's most recent funding round was for $45M (USD) in February 2021.

How much has Aspira Women's Health raised to-date?

As of Feb 4, 2021, Aspira Women's Health has raised a total of $146M (USD).

How many employees does Aspira Women's Health have?

Aspira Women's Health has 85 employees as of Feb 6, 2024.

Aspira Women's Health - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Diagnostic Tests
  • Treatments
Tags
  • Healthtech
Unique IDs
  • ein: 330595156
  • secCik: 0000926617
  • ticker: AWHL
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2835In Vitro And In Vivo Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325413In-Vitro Diagnostic Substance Manufacturing
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment